Literature DB >> 26972042

The impact of supplementary immunization activities on the epidemiology of measles in Tianjin, China.

Abram L Wagner1, Ying Zhang2, Bhramar Mukherjee3, Yaxing Ding2, Eden V Wells4, Matthew L Boulton4.   

Abstract

OBJECTIVES: China has repeatedly used supplemental immunization activities (SIAs) to work towards measles elimination, but it is unknown if the SIAs are reaching non-locals - migrants from rural to urban areas. This study characterized temporal trends in measles incidence by local and non-local residency and evaluated the impact of SIAs on measles incidence in Tianjin, China.
METHODS: Daily measles case-counts were tabulated separately by residency. These two datasets were combined so that each day had two observations. Poisson regression was conducted using generalized estimating equations with an exchangeable working correlation structure to estimate rate ratios (RRs).
RESULTS: There were 12465 measles cases in Tianjin over the 10-year period. The rate of measles was higher in non-locals than locals before the 2008 SIA (RR 3.60, 95% confidence interval (CI) 3.27-3.96), but this attenuated to a RR of 1.22 between the 2008 and 2010 SIAs (95% CI 1.02-1.45). Following the 2010 SIA, non-locals had a lower rate of measles (RR 0.78, 95% CI 0.69-0.87).
CONCLUSIONS: The disparity in measles incidence between locals and non-locals was reduced following two SIAs. Sustained public health interventions will be needed to maintain low measles incidence among non-locals given the ongoing migration of people throughout China.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  China; Mass vaccination; Measles

Mesh:

Year:  2016        PMID: 26972042      PMCID: PMC4834250          DOI: 10.1016/j.ijid.2016.03.005

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  19 in total

1.  Cost-effectiveness of three different vaccination strategies against measles in Zambian children.

Authors:  Gustavo H Dayan; Lisa Cairns; Nalinee Sangrujee; Anne Mtonga; Van Nguyen; Peter Strebel
Journal:  Vaccine       Date:  2004-01-02       Impact factor: 3.641

2.  The role of the China Experts Advisory Committee on Immunization Program.

Authors:  Jingshan Zheng; Yuqing Zhou; Huaqing Wang; Xiaofeng Liang
Journal:  Vaccine       Date:  2010-04-19       Impact factor: 3.641

3.  Measles vaccines: WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2009-08-28

Review 4.  Field effectiveness of live attenuated measles-containing vaccines: a review of published literature.

Authors:  Amra Uzicanin; Laura Zimmerman
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

5.  Supplementary immunization activities to achieve measles elimination: experience of the European Region.

Authors:  Nino Khetsuriani; Sergei Deshevoi; Ajay Goel; John Spika; Rebecca Martin; Nedret Emiroglu
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

6.  The Americas: paving the road toward global measles eradication.

Authors:  Carlos Castillo-Solorzano C; Cuauhtémoc Ruiz Matus; Brendan Flannery; Christina Marsigli; Gina Tambini; Jon Kim Andrus
Journal:  J Infect Dis       Date:  2011-07       Impact factor: 5.226

7.  Immunization status and risk factors of migrant children in densely populated areas of Beijing, China.

Authors:  Meiping Sun; Rui Ma; Yang Zeng; Fengji Luo; Jing Zhang; Wenjun Hou
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641

8.  Measles vaccine in the People's Republic of China.

Authors:  J Z Xiang; Z H Chen
Journal:  Rev Infect Dis       Date:  1983 May-Jun

9.  Progress in accelerated measles control in the People's Republic of China, 1991-2000.

Authors:  Wang Lixia; Zeng Guang; Lisa A Lee; Yang Zhiwei; Yu Jingjin; Zhou Jun; Liang Xiaofeng; Xu Chang; Bai Huqun
Journal:  J Infect Dis       Date:  2003-05-15       Impact factor: 5.226

10.  Measles resurgence associated with continued circulation of genotype H1 viruses in China, 2005.

Authors:  Yixin Ji; Yan Zhang; Songtao Xu; Zhen Zhu; Shuyan Zuo; Xiaohong Jiang; Peishan Lu; Changyin Wang; Yong Liang; Huanying Zheng; Yang Liu; Naiying Mao; Xiaofeng Liang; David Alexander Featherstone; Paul A Rota; William J Bellini; Wenbo Xu
Journal:  Virol J       Date:  2009-09-08       Impact factor: 4.099

View more
  5 in total

1.  Measles vaccination of young infants in China: A cost-effectiveness analysis.

Authors:  Cara Bess Janusz; Abram L Wagner; Nina B Masters; Yaxing Ding; Ying Zhang; David W Hutton; Matthew L Boulton
Journal:  Vaccine       Date:  2020-05-22       Impact factor: 3.641

2.  Measles Antibodies in Mother-Infant Dyads in Tianjin, China.

Authors:  Matthew L Boulton; Xiexiu Wang; Abram L Wagner; Ying Zhang; Bradley F Carlson; Brenda W Gillespie; Yaxing Ding
Journal:  J Infect Dis       Date:  2017-11-27       Impact factor: 5.226

3.  The measles epidemic trend over the past 30 years in a central district in Shanghai, China.

Authors:  Jie Gao; Bing Shen; JianJing Xiong; Yihan Lu; Qingwu Jiang
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

4.  Who should be prioritized for COVID-19 vaccination in China? A descriptive study.

Authors:  Juan Yang; Wen Zheng; Huilin Shi; Xuemei Yan; Kaige Dong; Qian You; Guangjie Zhong; Hui Gong; Zhiyuan Chen; Mark Jit; Cecile Viboud; Marco Ajelli; Hongjie Yu
Journal:  BMC Med       Date:  2021-02-10       Impact factor: 8.775

5.  Trends of vaccine-preventable diseases in Afghanistan from the Disease Early Warning System, 2009-2015.

Authors:  Abram L Wagner; Mohammad Y Mubarak; Laura E Johnson; Julia M Porth; Jenna E Yousif; Matthew L Boulton
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.